Skip to content

Celcuity CELC Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Tango Therapeutics logo
Tango TherapeuticsTNGX
Tenet Healthcare logo
Tenet HealthcareTHC
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's common stock, shares issued (in shares)?
Celcuity (CELC) reported common stock, shares issued (in shares) of $48.35M in Q1 2026.
How has Celcuity's common stock, shares issued (in shares) changed year-over-year?
Celcuity's common stock, shares issued (in shares) increased by 27.8% year-over-year, from $37.84M to $48.35M.
What is the long-term trend for Celcuity's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Celcuity's common stock, shares issued (in shares) has grown at a 36.2% compound annual growth rate (CAGR), from $10.3M to $48.24M.